Cold Feet on Wegovy: What's Happening and When to Act

Cold extremities aren't listed among the common side effects in the Wegovy SmPC, but they are reported by people on semaglutide treatment — particularly early on.
Reduced calorie intake and rapid weight loss can temporarily affect how your body distributes heat, which may explain sensations of coldness in the feet and hands.
A slower heart rate (bradycardia-adjacent slowing) and reduced metabolic output during weight loss are both recognised contributors to feeling colder than usual.
Persistent, painful, or one-sided cold feet warrant a conversation with a prescriber or GP, as other causes should be ruled out.

Some people notice cold feet, or a general feeling of coldness in their extremities, after starting Wegovy. This is a reported experience during semaglutide treatment, and while it isn't listed as a common side effect in the official prescribing information, there are plausible physiological reasons it happens — particularly in the first weeks of treatment. Here's what the clinical picture actually tells us, and what's worth discussing with your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the clinical evidence and prescribing guidance tell us about coldness on semaglutide

What Wegovy does to your metabolism, and why that changes how warm you feel

The STEP 1 trial, published in the New England Journal of Medicine, showed an average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. That kind of sustained calorie deficit has predictable downstream effects on thermoregulation. When the body is running at a lower energy intake, it produces less metabolic heat. Blood flow to peripheral tissues, including the feet, can reduce as the body prioritises warmth for the core organs. This isn't unique to semaglutide (it's a pattern seen across calorie-restricted weight-loss approaches) but the appetite suppression Wegovy produces can make the deficit more pronounced than people expect.

Semaglutide also slows gastric emptying, which affects how quickly nutrients enter the bloodstream. In the early weeks, before the body adjusts, energy availability can dip in ways that amplify that cold feeling, and you can read more about how semaglutide affects cold hands and feet in people going through this process. Most people find this settles as they stabilise at a given dose. If you're curious about the wider range of temperature-related experiences people report, feeling cold on Wegovy more generally covers the picture in more detail.

Is cold feet a recognised side effect, or something else entirely?

The NHS medicines page for semaglutide lists the common and serious side effects of Wegovy in plain language. Cold extremities don't appear there as a named common side effect. That matters, because it means you shouldn't automatically assume your cold feet are a direct pharmacological effect of semaglutide in the way that nausea or diarrhoea would be.

There are other explanations worth considering. Raynaud's phenomenon (episodic narrowing of small blood vessels in the fingers and toes triggered by cold or stress) becomes more noticeable during periods of significant physical change. Anaemia, which can develop if dietary protein and iron intake drop during weight loss, also causes cold extremities. Thyroid changes, peripheral arterial disease, and nerve-related conditions are all possibilities that a GP can check quickly. The point isn't to alarm; it's to say that cold and uncomfortable feet specifically on Wegovy can have several concurrent causes, and a single conversation with a clinician tends to resolve most of the uncertainty. Worth checking.

When cold feet on Wegovy need prompt attention

Most reports of cold feet during semaglutide treatment are bilateral (both feet), mild, and tied to early dose stages or periods of very low food intake, and our page on whether you feel cold on Wegovy explores why some people are more affected than others at these stages. These tend to improve without intervention once eating patterns stabilise and the body acclimates to the new metabolic baseline.

Some presentations are different and need faster attention. If one foot is significantly colder than the other, if the skin is pale, blue or mottled, if there is pain at rest or ulcers that won't heal, or if the coldness appeared suddenly alongside chest pain or breathlessness, get medical assessment promptly. These patterns can indicate circulatory problems unrelated to weight-loss treatment that happen to have surfaced at the same time.

The MHRA's Yellow Card scheme exists precisely for experiences like this: suspected side effects that don't fit the familiar list. Reporting through Yellow Card helps regulators identify signals that weren't captured in trials, and it's open to patients as well as clinicians. If your cold feet feel like a reaction to Wegovy, reporting it is genuinely useful, not just a box-ticking exercise.

Practical steps while you're on treatment

If cold feet are making things uncomfortable, a few practical adjustments are worth trying before escalating. Ensuring adequate protein intake (lean meat, fish, eggs, legumes) helps preserve muscle and supports circulation. Staying well hydrated matters more than many people realise during active weight loss, dehydration concentrates blood and makes peripheral circulation sluggish. Gentle movement, even short walks, keeps blood moving to the extremities. Wool socks are not a glamorous intervention, but they work.

On the clinical side, your prescriber can review whether the current dose pace is right for you. Slowing titration is sometimes appropriate when side effects are affecting quality of life, and our guide to semaglutide and feeling cold covers what to discuss with your prescriber if this is becoming a persistent issue. For people considering their options or wondering whether Wegovy is the right treatment for their situation, our team at nume... the nume clinical team reviews each case individually, and there's no algorithm making that call. You can explore the full range of weight-loss treatment options we offer, or read more about how semaglutide works as a treatment. When you're ready, check your eligibility with a free consultation, a prescriber will look at your full picture, including any symptoms you're managing.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions